Abstract:The Hippo pathway plays an evolutionarily conserved fundamental role in controlling organ size in multicellular organisms. Importantly, evidence from studies of patient samples and mouse models clearly indicates that deregulation of the Hippo signaling pathway plays a crucial role in the initiation and progression of many different types of human cancers. The Hippo signaling pathway is regulated by various stimuli, such as mechanical stress, G-protein coupled receptor signaling, and cellular energy status. When activated, the Hippo kinase cascade phosphorylates and inhibits the transcription co-activator YAP (Yes-associated protein), and its paralog TAZ (transcriptional coactivator with PDZ-binding motif), resulting in their cytoplasmic retention and degradation. When the Hippo signaling pathway is inactive, dephosphorylated YAP/TAZ translocate into the nucleus and activate gene transcription through binding to TEAD (TEA domain) family and other transcription factors. Such changes in gene expression promote cell proliferation and stem cell/progenitor cell self-renewal but inhibit apoptosis, thereby coordinately promote increase in organ size, tissue regeneration, and tumorigenesis. In this review, we summarize the molecular mechanisms of the mammalian Hippo signaling pathway with special emphasis on the Hippo kinase cascade and its upstream signals, the Hippo signaling pathway regulation of YAP and the mechanisms of YAP in regulation of gene transcription.

Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway

The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

Structural Insights into the YAP and TEAD Complex.

Molecular mechanisms of the mammalian Hippo signaling pathway.

The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis: an Updated Version.

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

TEAD Mediates YAP-dependent Gene Induction and Growth Control

YAP/TAZ for cancer therapy: Opportunities and challenges (Review)

YAP/TAZ for Cancer Therapy: Opportunities and Challenges (Review).

The Regulation and Function of YAP Transcription Co-Activator

Structural Basis of YAP Recognition by TEAD4 in the Hippo Pathway.

Targeting Yap/Taz-Tead Protein-Protein Interactions Using Fragment-Based And Computational Modeling Approaches

The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway.

The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal

Inactivation of Yap Oncoprotein by the Hippo Pathway is Involved in Cell Contact Inhibition and Tissue Growth Control

Insights into the Regulation of Yap/Taz from Cellular Systems and Mouse Models

The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment

Harness the power: new insights into the inhibition of YAP/Yorkie.

An overview of signaling pathways regulating YAP/TAZ activity

Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex

A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.